Skip to main content
. 2011 Dec 10;378(9808):2013–2020. doi: 10.1016/S0140-6736(11)61125-2

Figure 6.

Figure 6

Incidence of site-specific cancer during total follow-up period

Conventions as in figure 1. Not including non-melanoma skin cancer, which was prospectively to be considered separately (561 [5·5%] vs 512 [5·0%]; risk ratio 1·08 [0·96–1·21]; p=0·22).